Form 8-K · Current report
CF Industries 8-K, filed Aug 5, 2026
- Filed
- CIK
- 0001324404
- Accession no.
- 0001104659-26-091275
Summary
CF Industries Holdings reported first-half and second-quarter 2026 financial results, including $1.2 billion in second-quarter adjusted EBITDA and $3.7 billion in trailing-twelve-month adjusted EBITDA. The company said it will host a conference call on August 6, 2026 to discuss results for the quarter ended June 30, 2026.
Key points
- Q2 2026 adjusted EBITDA was $1.2B and trailing-twelve-month adjusted EBITDA was $3.7B.
- Q2 2026 trailing-twelve-month cash from operations was $3.0B and free cash flow was $1.8B.
- 1H 2026 available ammonia capacity utilization was 98%, and the 12-month rolling average recordable incident rate was 0.16.
- Management expects the Yazoo City Complex to resume operations in 1H 2027.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 2.02Results of Operations and Financial Condition
- 9.01Financial Statements and Exhibits
From the filing
Item 2.02. Results of Operations and Financial Condition. On August 6, 2026, CF Industries Holdings, Inc. will host a conference call discussing its results for the quarter ended June 30, 2026, at which the presentation attached hereto as Exhibit 99.1 will be used. The information set forth herein, including the exhibit attached hereto, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in any such filing. Item 9.01. Financial Statements and Exhibits. (d) Exhibits. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.